EP 1163518 A2 20011219 - ELISA KIT FOR THE DETERMINATION OF METABOLIC PHENOTYPES
Title (en)
ELISA KIT FOR THE DETERMINATION OF METABOLIC PHENOTYPES
Title (de)
ELISA ZUR BESTIMMUNG METABOLISCHER PHENOTYPEN
Title (fr)
KIT ELISA POUR LA DETERMINATION DE PHENOTYPES METABOLIQUES
Publication
Application
Priority
- CA 0000246 W 20000309
- US 12448899 P 19990315
Abstract (en)
[origin: WO0055624A2] The invention relates to an enzyme linked immunosorbent assay (ELISA) kit for the rapid determination of metabolic phenotypes including but not limited to CYP 1A2, N-acetyltamferase-1 (NAT-1), CYP 2P6, CYP 2E1 and CYP 3A4, which can be used on a routine basis in a clinical laboratory. The ELISA kit allows physicians to a) individualize therapy of drugs such as theophylline, tamoxifen, and clozapine and b) to predict susceptibility to carcinogen induced diseases such as colon rectal cancers. To reduce the number of patients undergoing clinical testing by selecting for patients with the appropriate phenotype most likely to respond.
IPC 1-7
IPC 8 full level
G01N 33/53 (2006.01); G01N 33/543 (2006.01); G01N 33/94 (2006.01)
CPC (source: EP)
G01N 33/94 (2013.01); G01N 2800/52 (2013.01)
Citation (search report)
See references of WO 0055624A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0055624 A2 20000921; WO 0055624 A3 20010201; AU 3138800 A 20001004; CA 2366085 A1 20000921; EP 1163518 A2 20011219; JP 2002539450 A 20021119
DOCDB simple family (application)
CA 0000246 W 20000309; AU 3138800 A 20000309; CA 2366085 A 20000309; EP 00908867 A 20000309; JP 2000605205 A 20000309